Dr Reddy's Laboratories Ltd
SWB:RDDA
Wall Street
Price Targets
RDDA Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
RDDA
is 12.75 EUR
with a low forecast of 9.73 EUR and a high forecast of 15.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RDDA's stock price target?
Price Target
12.75
EUR
According to Wall Street analysts, the average 1-year price target for
RDDA
is 12.75 EUR
with a low forecast of 9.73 EUR and a high forecast of 15.95 EUR.
What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
7%.
What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
-1%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
10%.
The projected
CAGR
for the next 3 years is
-1%.
What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
-1%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's net income is
12%.
The projected
CAGR
for the next 3 years is
-1%.
